• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

疫苗自主、地方能力与全球化:百日咳疫苗历史的教训

Vaccine independence, local competences and globalisation: lessons from the history of pertussis vaccines.

作者信息

Blume Stuart, Zanders Mariska

机构信息

University of Amsterdam, Amsterdam, The Netherlands.

出版信息

Soc Sci Med. 2006 Oct;63(7):1825-35. doi: 10.1016/j.socscimed.2006.04.014. Epub 2006 Jun 9.

DOI:10.1016/j.socscimed.2006.04.014
PMID:16764977
Abstract

In the context of global vaccine politics 'vaccine independence' has been defined as the assumption of financial responsibility for vaccine procurement. This paper suggests 'the possibility of vaccine choice' as an alternative meaning for the term. How far does local competence in vaccine development and production provide that possibility? Coupled to the national vaccination programme, such competence enabled the Netherlands to make use of a polio vaccine (Inactivated Polio Vaccine, or IPV) that it was felt best met national needs even though the rest of the world had switched to the alternative attenuated vaccine (generally known as Oral Polio Vaccine, or OPV); by the 1970s IPV was no longer commercially available. Over the past 20 years major changes in vaccine politics have occurred. Does the earlier conclusion regarding local competence still hold? The more recent example of pertussis (or whooping cough) vaccines, where again controversy surrounds the relative merits of alternative vaccines, permits the question to be posed anew. Results of our analysis from the Netherlands suggest, first, that the pressure to conform has become greater, and second, that the taken-for-granted globalism of today's vaccine system is in need of critical examination.

摘要

在全球疫苗政治背景下,“疫苗独立”被定义为承担疫苗采购的财政责任。本文提出“疫苗选择的可能性”作为该术语的另一种含义。地方在疫苗研发和生产方面的能力在多大程度上提供了这种可能性?与国家疫苗接种计划相结合,这种能力使荷兰能够使用一种脊髓灰质炎疫苗(灭活脊髓灰质炎疫苗,即IPV),尽管世界其他地区已转而使用另一种减毒疫苗(通常称为口服脊髓灰质炎疫苗,即OPV),但人们认为这种疫苗最能满足国家需求;到20世纪70年代,IPV已不再有商业供应。在过去20年里,疫苗政治发生了重大变化。关于地方能力的早期结论是否仍然成立?百日咳疫苗的最新例子再次引发了关于替代疫苗相对优缺点的争议,这使得这个问题可以重新提出。我们来自荷兰的分析结果表明,首先,顺应的压力变得更大,其次,当今疫苗系统中被视为理所当然的全球主义需要进行批判性审视。

相似文献

1
Vaccine independence, local competences and globalisation: lessons from the history of pertussis vaccines.疫苗自主、地方能力与全球化:百日咳疫苗历史的教训
Soc Sci Med. 2006 Oct;63(7):1825-35. doi: 10.1016/j.socscimed.2006.04.014. Epub 2006 Jun 9.
2
Acellular pertussis vaccines in Japan: past, present and future.日本的无细胞百日咳疫苗:过去、现在与未来。
Expert Rev Vaccines. 2005 Apr;4(2):173-84. doi: 10.1586/14760584.4.2.173.
3
Pertussis before and after the introduction of acellular pertussis vaccines in Finland.芬兰引入无细胞百日咳疫苗前后的百日咳情况
Vaccine. 2009 Sep 4;27(40):5443-9. doi: 10.1016/j.vaccine.2009.07.010. Epub 2009 Jul 21.
4
Recent improvements in polio and pertussis vaccination policy in Israel, 2005.2005年以色列脊髓灰质炎和百日咳疫苗接种政策的近期改进。
Isr Med Assoc J. 2006 May;8(5):319-21.
5
[Health Council of the Netherlands advisory report 'Vaccination against pertussis'--time for a new vaccine].[荷兰卫生委员会咨询报告《百日咳疫苗接种——新型疫苗的时机》]
Ned Tijdschr Geneeskd. 2004 May 8;148(19):916-8.
6
IgG responses after booster vaccination with different pertussis vaccines in Dutch children 4 years of age: effect of vaccine antigen content.荷兰4岁儿童接种不同百日咳疫苗加强针后的IgG反应:疫苗抗原含量的影响。
Vaccine. 2009 Nov 5;27(47):6530-6. doi: 10.1016/j.vaccine.2009.08.052. Epub 2009 Sep 1.
7
Long-term follow-up of Swedish children vaccinated with acellular pertussis vaccines at 3, 5, and 12 months of age indicates the need for a booster dose at 5 to 7 years of age.对瑞典在3、5和12月龄接种无细胞百日咳疫苗的儿童进行长期随访表明,5至7岁时需要加强一剂疫苗。
Pediatrics. 2006 Sep;118(3):978-84. doi: 10.1542/peds.2005-2746.
8
Diphtheria-tetanus-acellular pertussis and inactivated poliovirus vaccines given separately or combined for booster dosing at 4-6 years of age.白喉-破伤风-无细胞百日咳疫苗和灭活脊髓灰质炎病毒疫苗,在4至6岁时单独或联合接种进行加强免疫。
Pediatr Infect Dis J. 2008 Apr;27(4):341-6. doi: 10.1097/INF.0b013e3181616180.
9
Modified intra-cerebral challenge assay for acellular pertussis vaccines: comparisons among whole cell and acellular vaccines.无细胞百日咳疫苗的改良脑内攻毒试验:全细胞疫苗与无细胞疫苗的比较
Vaccine. 2009 Nov 16;27(49):6824-32. doi: 10.1016/j.vaccine.2009.09.014. Epub 2009 Sep 16.
10
Control of pertussis--lessons learnt from a 10-year surveillance programme in Sweden.百日咳的控制——瑞典一项为期10年监测计划的经验教训
Vaccine. 2009 Sep 25;27(42):5709-18. doi: 10.1016/j.vaccine.2009.07.092. Epub 2009 Aug 11.

引用本文的文献

1
Global property rights and land use efficiency.全球产权与土地利用效率。
Nat Commun. 2024 Oct 2;15(1):8525. doi: 10.1038/s41467-024-52859-5.
2
The dichotomy of pathogens and allergens in vaccination approaches.疫苗接种方法中病原体和过敏原的二分法。
Front Microbiol. 2014 Jul 16;5:365. doi: 10.3389/fmicb.2014.00365. eCollection 2014.
3
Determinants of refusal of A/H1N1 pandemic vaccination in a high risk population: a qualitative approach.高危人群拒绝接种 A/H1N1 大流行疫苗的决定因素:一种定性方法。
PLoS One. 2012;7(4):e34054. doi: 10.1371/journal.pone.0034054. Epub 2012 Apr 10.
4
State strategies of governance in biomedical innovation: aligning conceptual approaches for understanding 'Rising Powers' in the global context.国家在生物医学创新方面的治理策略:在全球背景下协调理解“新兴大国”的概念方法。
Global Health. 2011 Feb 24;7:3. doi: 10.1186/1744-8603-7-3.
5
Evidence and policymaking: The introduction of MMR vaccine in the Netherlands.证据与决策制定:荷兰引进麻疹-腮腺炎-风疹联合疫苗。
Soc Sci Med. 2010 Sep;71(6):1049-55. doi: 10.1016/j.socscimed.2010.06.023. Epub 2010 Jul 13.